SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Traube Robert J.

(Last) (First) (Middle)
C/O ZUORA, INC.
3050 S. DELAWARE ST., #301

(Street)
SAN MATEO CA 94403

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ZUORA INC [ ZUO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Revenue Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/30/2019
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 10/30/2019 A 100,000(1)(2) A $0 100,000 D
Class A Common Stock 10/30/2019 A 100,000(1)(3) A $0 200,000 D
Class A Common Stock 10/31/2019 S(4) 48,973 D $14.39 151,027 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to buy Class A Common Stock) $14.35 10/30/2019 A 75,000 (5) 10/30/2029 Class A Common Stock 75,000 $0 75,000 D
Stock Option (Right to buy Class A Common Stock) $14.35 10/30/2019 A 50,000 (6) 10/30/2029 Class A Common Stock 50,000 $0 100,000 D
Stock Option (Right to buy Class A Common Stock) $14.35 10/30/2019 A 250,000 (7) 10/30/2029 Class A Common Stock 250,000 $0 500,000 D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration.
2. The RSU vests over four years, with 1/4 of the total shares vesting on September 30, 2020 and the remaining shares vesting as to 1/16 of the total shares quarterly thereafter, so long as the Reporting Person continues to provide services to the Issuer through each vesting date.
3. The RSU vested fully on October 30, 2019, the Reporting Person's employment start date with the Issuer.
4. This transaction represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs listed in row 2 of Table I. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
5. The option vests over four years, with 1/48 of the total shares vesting on the first monthly anniversary of the vesting commencement date and the remaining shares vesting as to 1/48 of the total shares monthly thereafter, so long as the Reporting Person continues to provide services to the Issuer through each vesting date. The vesting commencement date for this option will be the vesting start date for the refresh stock grants to be awarded to the other members of Zuora's executive management team in calendar year 2021 (provided that such date shall be no later than May 1, 2021).
6. The option vests over four years, with 1/48 of the total shares vesting on the first monthly anniversary of the vesting commencement date and the remaining shares vesting as to 1/48 of the total shares monthly thereafter, so long as the Reporting Person continues to provide services to the Issuer through each vesting date. The vesting commencement date for this option will be the vesting start date for the refresh stock grants to be awarded to the other members of Zuora's executive management team in calendar year 2022 (provided that such date shall be no later than May 1, 2022).
7. The option vests over four years, with 1/4 of the total shares vesting on October 30, 2020 and the remaining shares vesting as to 1/48 of the total shares monthly thereafter, so long as the Reporting Person continues to provide services to the Issuer through each vesting date.
Remarks:
/s/ Jennifer Pileggi as attorney-in-fact for Robert J. Traube 11/01/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.